{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:00:01Z","timestamp":1793761201711,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007797","name":"Helsingin Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005744","name":"Lastentautien Tutkimussaatio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.clim.2021.108851","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T19:33:12Z","timestamp":1631129592000},"page":"108851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections"],"prefix":"10.1016","volume":"231","author":[{"given":"Iivo","family":"Hetem\u00e4ki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saila","family":"Laakso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannamari","family":"V\u00e4limaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iivari","family":"Kleino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliisa","family":"Kek\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Petteri","family":"Arstila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clim.2021.108851_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030289","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","author":"Meager","year":"2006","journal-title":"PLoS Med."},{"issue":"7","key":"10.1016\/j.clim.2021.108851_bb0010","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1182\/blood-2008-03-144634","article-title":"Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes","volume":"112","author":"Kisand","year":"2008","journal-title":"Blood."},{"issue":"7","key":"10.1016\/j.clim.2021.108851_bb0015","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210554","article-title":"Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1","volume":"218","author":"Bastard","year":"2021","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.clim.2021.108851_bb0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaci.2021.03.034","article-title":"Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis","volume":"148","author":"Lemarquis","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2021.108851_bb0025","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cell.2016.06.024","article-title":"AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies","volume":"166","author":"Meyer","year":"2016","journal-title":"Cell."},{"key":"10.1016\/j.clim.2021.108851_bb0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1749-6632.2011.06308.x","article-title":"Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome","volume":"1246","author":"Kisand","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.clim.2021.108851_bb0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.clim.2021.108851_bb0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.clim.2021.108851_bb0045","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139980","article-title":"Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency","volume":"131","author":"Bastard","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.clim.2021.108851_bb0050","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/eji.202048793","article-title":"Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway","volume":"51","author":"Meyts","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"6515","key":"10.1016\/j.clim.2021.108851_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.clim.2021.108851_bb0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0002-9343(88)80333-4","article-title":"Recombinant interferon alpha-2a for treatment of herpes zoster in immunosuppressed patients with cancer","volume":"85","author":"Winston","year":"1988","journal-title":"Am. J. Med."},{"issue":"11","key":"10.1016\/j.clim.2021.108851_bb0065","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1136\/annrheumdis-2015-208562","article-title":"Sifalimumab, an anti-interferon-alpha monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study","volume":"75","author":"Khamashta","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.clim.2021.108851_bb0070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an anti-interferon-alpha receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus","volume":"69","author":"Furie","year":"2017","journal-title":"Arthritis Rheumatol. (Hoboken, NJ)"},{"issue":"5","key":"10.1016\/j.clim.2021.108851_bb0075","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.mpg.0000243432.09216.aa","article-title":"Varicella recurrence complicated by pneumonia after liver transplantation for APECED","volume":"44","author":"Batra","year":"2007","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"6","key":"10.1016\/j.clim.2021.108851_bb0080","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2796.2007.01786.x","article-title":"Recurrent herpes simplex virus infection in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy associated with L29P and IVS9-1G>C compound heterozygous autoimmune regulator gene mutations","volume":"261","author":"Nagafuchi","year":"2007","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clim.2021.108851_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fendo.2020.00109","article-title":"Severe phenotype of APECED (APS1) increases risk for structural bone alterations","volume":"11","author":"Laakso","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.clim.2021.108851_bb0090","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3389\/fimmu.2020.02020","article-title":"The safety and efficacy of live viral vaccines in patients with cartilage-hair hypoplasia","volume":"11","author":"Vakkilainen","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2021.108851_bb0095","doi-asserted-by":"crossref","first-page":"20104","DOI":"10.1038\/srep20104","article-title":"Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1","volume":"6","author":"Landegren","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.clim.2021.108851_bb0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.clim.2021.108851_bb0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/INF.0b013e3181586665","article-title":"The burden of varicella complications before the introduction of routine varicella vaccination in Germany","volume":"27","author":"Liese","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"6","key":"10.1016\/j.clim.2021.108851_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.clim.2021.108851_bb0115","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1172\/JCI91162","article-title":"Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency","volume":"126","author":"Walter","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2021.108851_bb0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12967-015-0695-6","article-title":"Anti-cytokine autoantibodies in postherpetic neuralgia","volume":"13","author":"Bayat","year":"2015","journal-title":"J. Transl. Med."},{"issue":"Rr-4","key":"10.1016\/j.clim.2021.108851_bb0125","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recommend. Rep. Morbid. Mortal. Weekly Rep. Recommend. Rep."},{"issue":"4","key":"10.1016\/j.clim.2021.108851_bb0130","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/CMR.13.4.602","article-title":"Passive immunity in prevention and treatment of infectious diseases","volume":"13","author":"Keller","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"issue":"6","key":"10.1016\/j.clim.2021.108851_bb0135","doi-asserted-by":"crossref","first-page":"e2207","DOI":"10.1210\/clinem\/dgaa140","article-title":"Patients with APECED have increased early mortality due to endocrine causes, malignancies and infections","volume":"105","author":"Borchers","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clim.2021.108851_bb0140","first-page":"e2207","article-title":"Auto-antibodies against type I IFNs in patients with life-threatening COVID-19","author":"Bastard","year":"2020","journal-title":"Science."},{"issue":"8","key":"10.1016\/j.clim.2021.108851_bb0145","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s40618-020-01323-4","article-title":"A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor","volume":"43","author":"Beccuti","year":"2020","journal-title":"J. Endocrinol. Investig."},{"issue":"4","key":"10.1016\/j.clim.2021.108851_bb0150","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine","volume":"218","author":"Bastard","year":"2021","journal-title":"J. Exp. Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:04:57Z","timestamp":1761494697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661621001881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":30,"alternative-id":["S1521661621001881"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108851","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108851"}}